JOSEPH DEBOE: Open Payments
NPI 1104358407 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$931 in 56 payments from 14 companies in 2025. Trend: 2023 $2,219 · 2024 $525 · 2025 $931
Food & beverage: $931
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 32 | $350 |
| Boston Scientific Corporation | 2 | $151 |
| Esperion Therapeutics, Inc. | 4 | $77 |
| Edwards Lifesciences Corporation | 2 | $50 |
| Amgen Inc. | 3 | $50 |
| Abbott Laboratories | 2 | $46 |
| Chiesi USA, Inc. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Alnylam Pharmaceuticals Inc. | 2 | $32 |
| Novo Nordisk Inc | 1 | $26 |
Products named: LEQVIO, WATCHMAN FLX, NEXLETOL, SAPIEN 3 Ultra RESILIA, OTEZLA, JUXTAPID, CAMZYOS, AMVUTTRA.
Industry payments across AZ — which companies pay providers there.
